Last updated: 16 July 2024 at 7:51pm EST

Matthew Kwietniak Net Worth




The estimated Net Worth of Matthew R. Kwietniak is at least $261 mil dollars as of 12 July 2024. Mr Kwietniak owns over 881 units of Avid Bioservices Inc stock worth over $251,400 and over the last few years he sold CDMO stock worth over $9,124.

Mr Kwietniak CDMO stock SEC Form 4 insiders trading

Mr has made over 13 trades of the Avid Bioservices Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 881 units of CDMO stock worth $9,339 on 12 July 2024.

The largest trade he's ever made was exercising 10,365 units of Avid Bioservices Inc stock on 28 June 2023 worth over $109,869. On average, Mr trades about 1,830 units every 27 days since 2023. As of 12 July 2024 he still owns at least 23,717 units of Avid Bioservices Inc stock.

You can see the complete history of Mr Kwietniak stock trades at the bottom of the page.





Mr. Matthew Kwietniak biography

Matthew Kwietniak is the Chief Commercial Officer at Avid Bioservices Inc.



What's Mr Kwietniak's mailing address?

Matthew's mailing address filed with the SEC is 14191, Myford Road, Walnut, Tustin, Orange County, California, 92780, United States.

Insiders trading at Avid Bioservices Inc

Over the last 7 years, insiders at Avid Bioservices Inc have traded over $1,839,814 worth of Avid Bioservices Inc stock and bought 460,748 units worth $3,573,760 . The most active insiders traders include Gregory Sargen, Nicholas Stewart Green, eMark R Bamforth. On average, Avid Bioservices Inc executives and independent directors trade stock every 16 days with the average trade being worth of $107,028. The most recent stock trade was executed by Richard A. Richieri on 12 July 2024, trading 1,469 units of CDMO stock currently worth $15,571.



What does Avid Bioservices Inc do?

avid bioservices, a subsidiary of peregrine pharmaceuticals, inc. (nasdaq: pphm), is a unique contract manufacturing organization ("cmo") partner dedicated to the development and production of monoclonal antibodies, recombinant proteins and enzymes produced in mammalian cell culture. our extensive experience at all stages of development enables us to provide comprehensive development, manufacturing and support services to navigate a biologic from concept to commercialization.



What does Avid Bioservices Inc's logo look like?

Avid Bioservices Inc logo

Complete history of Mr Kwietniak stock trades at Avid Bioservices Inc

Data
#
Companhia
Acionista maioritário
Trans.
Transação
Ações Preço por ação Preço total Ações após Fonte
12 Jul 2024 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 881 $8.32 $7,330
12 Jul 2024
23,717
11 Jul 2024 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 335 $8.00 $2,680
11 Jul 2024
22,955
9 Jul 2024 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 1,267 $7.58 $9,604
9 Jul 2024
23,064
30 Apr 2024 Matthew R. Kwietniak
Chief Commercial Officer
Venda 1,233 $7.40 $9,124
30 Apr 2024
21,797
11 Apr 2024 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 669 $6.90 $4,616
11 Apr 2024
23,030
9 Apr 2024 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 2,532 $7.19 $18,205
9 Apr 2024
22,361
11 Jan 2024 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 669 $6.76 $4,522
11 Jan 2024
20,103
9 Jan 2024 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 2,533 $6.29 $15,933
9 Jan 2024
20,494
11 Oct 2023 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 670 $9.29 $6,224
11 Oct 2023
18,216
9 Oct 2023 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 2,532 $9.43 $23,877
9 Oct 2023
18,516
11 Jul 2023 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 669 $13.36 $8,938
11 Jul 2023
16,236
9 Jul 2023 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 1,261 $13.92 $17,553
9 Jul 2023
16,044
28 Jun 2023 Matthew R. Kwietniak
Chief Commercial Officer
Exercício de opção 10,365 $12.96 $134,330
28 Jun 2023
18,014


Avid Bioservices Inc executives and stock owners

Avid Bioservices Inc executives and other stock owners filed with the SEC include: